首页> 外国专利> PROPHYLAXIS AND TREATMENT OF ENTEROCOLITIS ASSOCIATED WITH ANTI-CTLA-4 ANTIBODY THERAPY

PROPHYLAXIS AND TREATMENT OF ENTEROCOLITIS ASSOCIATED WITH ANTI-CTLA-4 ANTIBODY THERAPY

机译：与抗CTLA-4抗体治疗相关的小肠结肠炎和小肠结肠炎的治疗

页面导航

摘要
著录项
相似文献

摘要

The present invention provides methods for reducing the incidence of adverse events related to immunotherapy. More specifically, the present invention provides methods for reducing the incidence of enterocolitis associated with anti- CTLA-4 antibody immunotherapy.

机译：本发明提供了减少与免疫疗法有关的不良事件发生率的方法。更具体地，本发明提供了减少与抗CTLA-4抗体免疫疗法有关的小肠结肠炎发生率的方法。

著录项

公开/公告号WO2007056539A3

专利类型
公开/公告日2008-11-20

原文格式PDF
申请/专利权人 MEDAREX INC.;UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES;FISCHKOFF STEVEN;LOWY ISRAEL;YANG JAMES CHUNG-YIN;TARGAN STEPHAN R.;
展开▼

申请/专利号WO2006US43690
发明设计人 YANG JAMES CHUNG-YIN;FISCHKOFF STEVEN;TARGAN STEPHAN R.;LOWY ISRAEL;
展开▼

申请日2006-11-08
分类号A01N45/00;A61K31/56;C07K16/00;
国家 WO
入库时间 2022-08-21 19:21:57

相似文献

专利
外文文献
中文文献